- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03204669
Trace Element Repletion Following Severe Burn Injury
June 28, 2017 updated by: Mette M Berger, Centre Hospitalier Universitaire Vaudois
Major burn patients are characterized by large exudative losses of Cu, Se and Zn.
Trace element (TE) repletion has been shown to improve clinical outcome.
The study aimed to check if our repletion protocols were achieving normalization of TE plasma concentrations of major burn patients and if the necessity for continuous renal replacement therapy (CRRT) might increase the needs.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Retrospective analysis of prospectively collected data in burn patients requiring intensive care (ICU) between 1999 and 2015.
The cohort was divided into 4 groups according to the protocol changes.
Period 1 (P1): 1999-2000, P2: 2001-2005, P3: 2006-2010, P4: 2011-2015.
Changes consisted mainly in increasing TE repletion doses and duration.
Demographic data, daily TE intakes and weekly plasma concentrations were retrieved for the first 21 ICU-days.
Study Type
Observational
Enrollment (Actual)
139
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lausanne, Switzerland, 1011
- Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 86 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Consecutive burns admissions to the ICU, between June 1st, 1999 and December 31st, 2015 in a Swiss quaternary care hospital (Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois).
Description
Inclusion Criteria:
- Burn injury involving ≥20% body surface (TBSA) (i.e. the threshold for intravenous TE repletion prescription)
- At least one TE plasma concentration during the ICU stay
Exclusion Criteria:
- Comfort care
- Admission >24h after burn injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trace elements plasma concentration
Time Frame: 21 days
|
Copper, Selenium and Zinc plasma concentrations, measured by inductively coupled plasma mass spectrometry (ICP-MS).
The recommendation was to check them on a weekly basis.
|
21 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of infectious complications
Time Frame: 21 days
|
Infectious complications retrieved from the discharge reports, based on microbiological findings and antibiotherapy introduction or rotation.
Multiple positive cultures were considered only once when they were related to a unique infectious episode.
Concomitant sites of infection, including primary bloodstream infections, were considered as separate episodes of infections.
Episodes of infections due to several microorganisms were considered only once.
Infections were defined according to the criteria of the Center for Disease Control (CDC), American Burn Association (ABA) and International sepsis forum.
|
21 days
|
|
Length of mechanical ventilation
Time Frame: Up to 120 days
|
Number of days on the ventilator by the time the patient is discharged from hospital.
|
Up to 120 days
|
|
Length of stay
Time Frame: Up to 250 days
|
Number of days spent in the ICU by the time the patient is discharged from hospital.
|
Up to 250 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract. 2006 Oct;21(5):438-49. doi: 10.1177/0115426506021005438.
- Shenkin A. The key role of micronutrients. Clin Nutr. 2006 Feb;25(1):1-13. doi: 10.1016/j.clnu.2005.11.006. Epub 2006 Jan 10.
- Berger MM, Baines M, Raffoul W, Benathan M, Chiolero RL, Reeves C, Revelly JP, Cayeux MC, Senechaud I, Shenkin A. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr. 2007 May;85(5):1293-300. doi: 10.1093/ajcn/85.5.1293.
- Berger MM, Spertini F, Shenkin A, Wardle C, Wiesner L, Schindler C, Chiolero RL. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr. 1998 Aug;68(2):365-71. doi: 10.1093/ajcn/68.2.365.
- Kurmis R, Greenwood J, Aromataris E. Trace Element Supplementation Following Severe Burn Injury: A Systematic Review and Meta-Analysis. J Burn Care Res. 2016 May-Jun;37(3):143-59. doi: 10.1097/BCR.0000000000000259.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 1999
Primary Completion (Actual)
December 31, 2015
Study Completion (Actual)
December 31, 2015
Study Registration Dates
First Submitted
June 26, 2017
First Submitted That Met QC Criteria
June 28, 2017
First Posted (Actual)
July 2, 2017
Study Record Updates
Last Update Posted (Actual)
July 2, 2017
Last Update Submitted That Met QC Criteria
June 28, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- X21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
Istanbul Medeniyet UniversityRecruiting
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
Clinical Trials on Trace elements replacement
-
Institute of Oncology LjubljanaRecruitingTrace Element DeficiencySlovenia
-
Cengiz Gokcek Women's and Children's HospitalCompleted
-
University of OxfordNational Center of Cardiology and Internal Medicine named after academician...WithdrawnHypertension, PulmonaryKyrgyzstan
-
Hospices Civils de LyonCompletedChronic HemolysisFrance
-
Frederick SchmittNational Cancer Institute (NCI); National Institute on Aging (NIA)CompletedAlzheimer DiseaseUnited States, Canada, Puerto Rico
-
Gil Joon SuhBiosyn; Boryung Pharmaceutical Co., LtdWithdrawnSepsis | Shock, SepticKorea, Republic of
-
Anemia Working Group RomaniaWithdrawnAnemia | Chronic Kidney Disease | Chronic Heart FailureRomania
-
University Hospital, ToulouseRecruiting
-
University of California, San FranciscoCompleted
-
Kasr El Aini HospitalCompleted